SCHEMBL7867175

SCHEMBL7867175

Cc1[nH]c(=O)c(CC(c2ccc(Cl)cc2)C2CC2)nc1CC(=O)NCCONC(=N)N

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
SLC6A3 Q01959 1/20 0.31
FPR2 P25090 2/20 0.31
PROKR1 Q8TCW9 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7876037 0.90 PDE2A (0.31)
SCHEMBL7872474 0.88 USP2 (0.34)
SCHEMBL7876222 0.87 OPRM1 (0.37)
SCHEMBL7876016 0.86 NOS1 (0.31)
SCHEMBL3241872 0.78 F2 (0.41)
SCHEMBL7874304 0.75
SCHEMBL7876040 0.73
SCHEMBL7874308 0.72 AURKA (0.31)
SCHEMBL7867229 0.72 F2 (0.44) SLC6A2SLC6A4SLC6A3
SCHEMBL7876212 0.72 F2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1086122-A1 PYRAZINONE PROTEASE INHIBITORS Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (US) 2001-03-28 EP claimed
WO-1999064446-A1 PYRAZINONE PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1999-12-16 WO claimed
EP-1086122-A1 PYRAZINONE PROTEASE INHIBITORS Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (US) 2001-03-28 EP disclosed
WO-1999064446-A1 PYRAZINONE PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1999-12-16 WO disclosed